HLA-B27 alters the response to tumor necrosis factor α and promotes osteoclastogenesis in bone marrow monocytes from HLA-B27-transgenic rats

Arthritis and Rheumatism

Volumn 65, Issue 8, 2013, Pages 2123-2131

  Layh Schmitt, Gerlinde ^a   Yang, Eva Y ^a   Kwon, Grace ^a   Colbert, Robert A ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHAPERONE; HLA B27 ANTIGEN; HLA B7 ANTIGEN; INTERLEUKIN 1ALPHA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEAVY CHAIN; HOMEOSTASIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MONOCYTE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; TRANSGENIC RAT; UPREGULATION; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BONE MARROW CELLS; BONE RESORPTION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; HLA-B27 ANTIGEN; HUMANS; MONOCYTES; OSTEOCLASTS; RANK LIGAND; RATS; RATS, INBRED LEW; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84881362894     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38001     Document Type: Article

References (42)

1. Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G,. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev 2010; 233: 181-202.
2. Benjamin R, Parham P,. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137-42.
3. + and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011; 186: 2672-80.
4. Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, Schmitt A, et al. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum 2007; 56: 1478-89.
5. Dhaenens M, Fert I, Glatigny S, Haerinck S, Poulain C, Donnadieu E, et al. Dendritic cells from spondylarthritis-prone HLA-B27-transgenic rats display altered cytoskeletal dynamics, class II major histocompatibility complex expression, and viability. Arthritis Rheum 2009; 60: 2622-32.
6. Utriainen L, Firmin D, Wright P, Cerovic V, Breban M, McInnes I, et al. Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis. Arthritis Rheum 2012; 64: 3199-209.
7. Glatigny S, Fert I, Blaton MA, Lories RJ, Araujo LM, Chiocchia G, et al. Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats. Arthritis Rheum 2012; 64: 110-20.
8. Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175: 2438-48.
9. Turner MJ, Delay ML, Bai S, Klenk E, Colbert RA,. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007; 56: 215-23.
10. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA,. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1. Eur J Immunol 2008; 38: 1194-203.
11. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA,. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-43.
12. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci U S A 2010; 107: 17698-703.
13. - entheseal resident T cells. Nat Med 2012; 18: 1069-76.
14. Feng Y, Ding J, Fan CM, Zhu P,. Interferon-γ contributes to HLA-B27-associated unfolded protein response in spondyloarthropathies. J Rheumatol 2012; 39: 574-82.
15. Will R, Palmer R, Bhalla AK, Ring F, Calin A,. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989; 2: 1483-5.
16. Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD,. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 117-21.
17. Klingberg E, Lorentzon M, Mellstrom D, Geijer M, Gothlin J, Hilme E, et al. Osteoporosis in ankylosing spondylitis-prevalence, risk factors and methods of assessment. Arthritis Res Ther 2012; 14: R108.
18. Akhter MP, Jung LK,. Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy. Rheumatology (Oxford) 2007; 46: 1258-62.
19. 2-m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112.
20. Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169: 209-23.
21. Dangoria NS, DeLay ML, Kingsbury DJ, Mear JP, Uchanska-Ziegler B, Ziegler A, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277: 23459-68.
22. 2-microglobulin. Immunogenetics 1987; 25: 228-33.
23. Stam NJ, Spits H, Ploegh HL,. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986; 137: 2299-306.
24. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 2002; 416: 744-9.
25. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000; 191: 275-86.
26. Ganley IG, Wong PM, Gammoh N, Jiang X,. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 2011; 42: 731-43.
27. Zeng L, Liu YP, Sha H, Chen H, Qi L, Smith JA,. XBP-1 couples endoplasmic reticulum stress to augmented IFN-β induction via a cis-acting enhancer in macrophages. J Immunol 2010; 185: 2324-30.
28. Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 2012; 3: e261.
29. El Maghraoui A,. Osteoporosis and ankylosing spondylitis. Joint Bone Spine 2004; 71: 291-5.
30. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, et al. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009; 44: 772-6.
31. Magrey M, Khan MA,. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 2010; 12: 332-6.
32. Francois RJ, Neure L, Sieper J, Braun J,. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases. Ann Rheum Dis 2006; 65: 713-20.
33. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, Kohler D, et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54: 2845-51.
34. Neidhart M, Baraliakos X, Seemayer C, Zelder C, Gay RE, Michel BA, et al. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann Rheum Dis 2009; 68: 1334-9.
35. Briot K, Gossec L, Kolta S, Dougados M, Roux C,. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-α treatment. J Rheumatol 2008; 35: 855-61.
36. Visvanathan S, van der Heijde D, Deodhar A, Wagner C, Baker DG, Han J, et al. Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 2009; 68: 175-82.
37. Maksymowych WP, Elewaut D, Schett G,. Motion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammation. Arthritis Rheum 2012; 64: 1713-9.
38. Papet I, El Yousfi M, Godin JP, Mermoud AF, Davicco MJ, Coxam V, et al. HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation. J Musculoskelet Neuronal Interact 2008; 8: 251-6.
39. Rauner M, Stupphann D, Haas M, Fert I, Glatigny S, Sipos W, et al. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. J Rheumatol 2009; 36: 120-6.
40. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA,. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-γ dysregulation. Arthritis Rheum 2008; 58: 1640-9.
41. Zeng L, Lindstrom MJ, Smith JA,. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum 2011; 63: 3807-17.
42. Dickhout JG, Lhotak S, Hilditch BA, Basseri S, Colgan SM, Lynn EG, et al. Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. FASEB J 2011; 25: 576-89.